Publications:103
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Children & Adults
Accepting New PatientsEdward Kim, MD
Interventional Radiology
No Patient Experience Ratings
Book an Appointment
About Me
Edward Kim, MD, is Director of Interventional Oncology and Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at the Mount Sinai Medical Center. After completing medical school at the University of Medicine and Dentistry New Jersey-New Jersey Medical School in 2001, he did his residency at Nassau University Medical Center and completed his fellowship in Vascular and Interventional Radiology at The Mount Sinai School of Medicine. He subsequently joined the division of Vascular and Interventional Radiology.
Dr. Kim lectures around the country on various subjects in the field of Vascular and Interventional Radiology, including chemoembolization, Y90 radioembolization, radiofrequency ablation, GPS navigation guidance for percutaneous procedures, biliary interventions and the endovascular management of endoleaks.
Dr. Kim’s interests are with the growing subspecialty of interventional oncology and is the principal investigator on various trials involving drug eluting beads for chemoembolization, as well as radioembolization. He is also a pioneer in the use of image guided interventions, particularly with regards to GPS and fusion techniques to decrease radiation exposure to patients.
Dr. Kim has authored various scientific abstracts and manuscripts in the field of Vascular and Interventional Radiology. He has also been invited as faculty at various meetings including The Society of Interventional Radiology Annual Meeting, Global Embolization Symposium and Technologies, Advanced Interventional Management and New York Roentgen Society Annual Meeting.
In the News:
- Dr. Kim weighs in on the advancements in treatment and how he, along with his team, are working to deliver the pinnacle of personalized care to patients.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Imaging, Liver
About Me
Edward Kim, MD, is Director of Interventional Oncology and Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at the Mount Sinai Medical Center. After completing medical school at the University of Medicine and Dentistry New Jersey-New Jersey Medical School in 2001, he did his residency at Nassau University Medical Center and completed his fellowship in Vascular and Interventional Radiology at The Mount Sinai School of Medicine. He subsequently joined the division of Vascular and Interventional Radiology.
Dr. Kim lectures around the country on various subjects in the field of Vascular and Interventional Radiology, including chemoembolization, Y90 radioembolization, radiofrequency ablation, GPS navigation guidance for percutaneous procedures, biliary interventions and the endovascular management of endoleaks.
Dr. Kim’s interests are with the growing subspecialty of interventional oncology and is the principal investigator on various trials involving drug eluting beads for chemoembolization, as well as radioembolization. He is also a pioneer in the use of image guided interventions, particularly with regards to GPS and fusion techniques to decrease radiation exposure to patients.
Dr. Kim has authored various scientific abstracts and manuscripts in the field of Vascular and Interventional Radiology. He has also been invited as faculty at various meetings including The Society of Interventional Radiology Annual Meeting, Global Embolization Symposium and Technologies, Advanced Interventional Management and New York Roentgen Society Annual Meeting.
In the News:
- Dr. Kim weighs in on the advancements in treatment and how he, along with his team, are working to deliver the pinnacle of personalized care to patients.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Imaging, Liver
Clinical Focus
- Angiography
- Interventional Oncology
- Interventional Radiology Treatment
- Portal Hypertension TIPS-Transjujular Intrahepatic Portosystemic Shunt
- Radiofrequency Ablation
- Renal Artery Stenosis
Education
MD, Rutgers New Jersey Medical School
Internship, Transitional Year
Morristown Memorial Hospital
Residency, Radiology, General
Nassau University Medical Center
Fellowship, Radiology, Vascular & Interventional Radiology
Mount Sinai Hospital
Certifications
American Board of Radiology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Physician Office5 E 98th Street, 12th Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Safety and Effectiveness of Yttrium-90 Radioembolization in People Living with Human Immunodeficiency Virus. Kartikeya M. Menon, Ricki A. Gottlieb, Thomas Marron, Jack Zhang, Vivian Bishay, Rahul Patel, Edward Kim, Kirema Garcia-Reyes. Journal of Vascular and Interventional Radiology
- CT/MRI LI-RADS 2024 Update: Treatment Response Assessment. Anum Aslam, Victoria Chernyak, Frank H. Miller, Mustafa Bashir, Richard Do, Claude Sirlin, Robert J. Lewandowski, Charles Y. Kim, Ania Zofia Kielar, Avinash R. Kambadakone, Hooman Yarmohammadi, Edward Kim, Dawn Owen, Resmi A. Charalel, Anuradha Shenoy-Bhangle, Lauren M. Burke, Mishal Mendiratta-Lala. Radiology
- Fertility after Transcatheter Arterial Embolization for Obstetric Hemorrhage: An Urban Health Care System Observational Study. Ariana C. Mills, Brett Marinelli, Emma D. Klein, Kirema Garcia-Reyes, Dan Shilo, Scott Nowakowski, Rahul Patel, Rajesh Patel, Edward Kim, Aaron Fischman, Vivian Bishay, Holly Loudon, Joanne Stone, Robert Lookstein. American Journal of Perinatology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Kim during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Eisai, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Kim during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Eisai, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.